Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway

Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway

Hyperlipidaemia is one of the major risk factors for atherosclerosis, coronary heart disease, stroke and diabetes. In the present study, we synthesized a new anthraquinone compound, 1,8-dihydroxy-3-succinic acid monoethyl ester-6-methylanthraquinone, and named it Kanglexin (KLX). The aim of this stu...

Full description

Bibliographic Details
Main Authors:	Xin Li, Xueling Hu, Tengfei Pan, Lei Dong, Lili Ding, Zhenzhong Wang, Rui Song, Xiuzhu Wang, Ning Wang, Yan Zhang, Jinhui Wang, Baofeng Yang
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	Biomedicine & Pharmacotherapy
Subjects:	Anthraquinone compound Kanglexin Hyperlipidaemia Fatty liver AMPK/SREBP-2/PCSK9/LDLR signalling pathway
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332220309951

Similar Items

Pterostilbene Increases LDL Metabolism in HL-1 Cardiomyocytes by Modulating the PCSK9/HNF1α/SREBP2/LDLR Signaling Cascade, Upregulating Epigenetic hsa-miR-335 and hsa-miR-6825, and LDL Receptor Expression
by: Yen-Kuang Lin, et al.
Published: (2021-08-01)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
by: Aikaterini Arida, et al.
Published: (2021-10-01)

Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway
by: Xue Liu, et al.
Published: (2021-01-01)

A New Strategy for Rapidly Screening Natural Inhibitors Targeting the PCSK9/LDLR Interaction In Vitro
by: Li Li, et al.
Published: (2018-09-01)

Serum sdLDL-C and cellular SREBP2-dependent cholesterol levels: Is there a challenge on targeting PCSK9?
by: Soltanmohammadi Elham, et al.
Published: (2016-01-01)

The association of LDLR and PCSK9 variants with LDL-c levels in a black South African population in epidemiological transition / Tertia van Zyl
by: Van Zyl, Tertia
Published: (2016)

The association of LDLR and PCSK9 variants with LDL-c levels in a black South African population in epidemiological transition / Tertia van Zyl
by: Van Zyl, Tertia
Published: (2016)

Caracterização funcional in vitro de variantes no gene PCSK9 identificadas em pacientes com Hipercolesterolemia Familial
by: Los, Bruna
Published: (2019)

17β-Estradiol Inhibits PCSK9-Mediated LDLR Degradation Through GPER/PLC Activation in HepG2 Cells
by: Wei Fu, et al.
Published: (2020-01-01)

PCSK9 and LDL-C: The Role of Exercise
by: Jaeho Jin, et al.
Published: (2020-11-01)

Patients With <italic toggle="yes">LDLR</italic> and <italic toggle="yes">PCSK9</italic> Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia
by: Takahito Doi, et al.
Published: (2021-02-01)

Élucidation et identification des différents interacteurs impliqués dans le mécanisme de régulation du LDLR par la protéine PCSK9
by: Ly, Kévin
Published: (2016)

LDLR and ApoB are Major Genetic Causes of Autosomal Dominant Hypercholesterolemia in a Taiwanese Population
by: Kai-Chien Yang, et al.
Published: (2007-10-01)

In Silico Insights into Protein–Protein Interaction Disruptive Mutations in the PCSK9-LDLR Complex
by: William R. Martin, et al.
Published: (2020-02-01)

Naturally Occurring PCSK9 Inhibitors
by: Maria Pia Adorni, et al.
Published: (2020-05-01)

Sulfated polysaccharide from Enteromorpha prolifera suppresses SREBP-1c and ACC expression to lower serum triglycerides in high-fat diet-induced hyperlipidaemic rats
by: Rendong Ren, et al.
Published: (2018-01-01)

The Cholesterol-Lowering Effect of Capsella Bursa-Pastoris Is Mediated via SREBP2 and HNF-1α-Regulated PCSK9 Inhibition in Obese Mice and HepG2 Cells
by: Jin-Taek Hwang, et al.
Published: (2021-02-01)

Mutational Spectrum of LDLR and PCSK9 Genes Identified in Iranian Patients With Premature Coronary Artery Disease and Familial Hypercholesterolemia
by: Arman Moradi, et al.
Published: (2021-02-01)

The <i>LDLR</i>, <i>APOB</i>, and <i>PCSK9</i> Variants of Index Patients with Familial Hypercholesterolemia in Russia
by: Alexey Meshkov, et al.
Published: (2021-01-01)

c-IAP1 Binds and Processes PCSK9 Protein: Linking the c-IAP1 in a TNF-α Pathway to PCSK9-Mediated LDLR Degradation Pathway
by: David Hornby, et al.
Published: (2012-10-01)

The Functional Characterization of PCSK9's Binding Interactions with LDL and the LDL Receptor
by: Matyas, Angela
Published: (2020)

The Cholesterol-Modulating Effect of Methanol Extract of Pigeon Pea (<i>Cajanus cajan</i> (L.) Millsp.) Leaves on Regulating LDLR and PCSK9 Expression in HepG2 Cells
by: Heng-Yuan Chang, et al.
Published: (2019-01-01)

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
by: Emma M. O’Connell, et al.
Published: (2020-06-01)

PCSK9 and Its Variants: An Unbiased Global Proteomic Study to Identify Interactors and Effects on Protein Trafficking
by: Chu, Ge
Published: (2015)

Lupin Peptide T9 (GQEQSHQDEGVIVR) Modulates the Mutant PCSK9<sup>D374Y</sup> Pathway: in vitro Characterization of its Dual Hypocholesterolemic Behavior
by: Carmen Lammi, et al.
Published: (2019-07-01)

Polymorphisms in PCSK9, LDLR, BCMO1, SLC12A3, and KCNJ1 Are Associated with Serum Lipid Profile in Chinese Han Population
by: Zheng Li, et al.
Published: (2019-09-01)

Ultrassequenciamento exômico dos principais genes relacionados com a hipercolesterolemia familial
by: Borges, Jéssica Bassani
Published: (2019)

Comparing expression and activity of PCSK9 in SPRET/EiJ and C57BL/6J mouse strains shows lack of correlation with plasma cholesterol
by: Francine Sirois, et al.
Published: (2017-03-01)

Genistein upregulates LDLR levels via JNK-mediated activation of SREBP-2
by: Medicia Kartawijaya, et al.
Published: (2016-05-01)

Characterization of PCSK9-mediated LDLR Degradation in Hepatic and Fibroblast Cells
by: Nguyen, My-Anh
Published: (2013)

Characterization of PCSK9-mediated LDLR Degradation in Hepatic and Fibroblast Cells
by: Nguyen, My-Anh
Published: (2013)

Discovery of Flavonoids from Scutellaria baicalensis with Inhibitory Activity Against PCSK 9 Expression: Isolation, Synthesis and Their Biological Evaluation
by: Piseth Nhoek, et al.
Published: (2018-02-01)

Di’ao Xinxuekang Capsule, a Chinese Medicinal Product, Decreases Serum Lipids Levels in High-Fat Diet-Fed ApoE–/– Mice by Downregulating PCSK9
by: Liping Qu, et al.
Published: (2018-11-01)

Prenylated Flavonoid Glycosides with PCSK9 mRNA Expression Inhibitory Activity from the Aerial Parts of <i>Epimedium koreanum</i>
by: Eeray Kim, et al.
Published: (2021-06-01)

Implication de la convertase NARC-1 / PCSK9 au cours de la différenciation neuroectodermale
by: Poirier, Steve
Published: (2016)

Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation
by: Di Sun, et al.
Published: (2018-11-01)

Prevention of atherosclerosis by modulating PCSK9 expression and function
by: Samami, Samaneh
Published: (2020)

Prevalence and Impact of Apolipoprotein E7 on LDL Cholesterol Among Patients With Familial Hypercholesterolemia
by: Hayato Tada, et al.
Published: (2021-04-01)

Organ Specific Differences in Alteration of Aquaporin Expression in Rats Treated with Sennoside A, Senna Anthraquinones and Rhubarb Anthraquinones
by: Zhaoyang Wang, et al.
Published: (2021-07-01)

Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation
by: Chunyi Wang, et al.
Published: (2018-04-01)